- Viridian may have edge over Amgen in eye drug showdown, analysts argue<figure><div><img src="https://imgproxy.divecdn.com/egbyTu8esim-VjYj5FTvMQUlBrndW-s35OSn02s-EoY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzk4NTE5MTYzLmpwZ…BioPharma Dive · 27d ago↗ source
- These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.<figure><div><img src="https://imgproxy.divecdn.com/gB0ZFwp5dREfmGbq6AMDBNj5FromoYE914x8tdybbBQ/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjIwMjU5MzY2LmpwZ…BioPharma Dive · 27d ago↗ source
- Beeline ups its Series A round for immune drug work<figure><div><img src="https://imgproxy.divecdn.com/4FSYxYVR65mzzE0lNMMPQjdujTL0_B50-03lC1bSrS8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8yWEtHQ0JZLmpwZw==.webp"/></div></f…